AI for Structure-Based Drug Discovery
Our Mission
The mission of the Artificial Intelligence for Structure-Based Drug Discovery program is to enable the design of safe, effective medicines by developing computational methods that leverage machine learning and three-dimensional molecular structure. The program will provide a forum for pharmaceutical industry scientists to guide Stanford research toward the most critical real-world problems and for Stanford researchers to guide deployment of cutting-edge algorithms and software in industry.
Dr. Ron Dror is an Associate Professor of Computer Science in the Stanford Artificial Intelligence Lab. Dr. Dror leads a research group that uses machine learning and molecular simulation to elucidate biomolecular structure, dynamics, and function, and to guide the development of more effective medicines. He collaborates extensively with experimentalists in both academia and industry.
